Skip to search formSkip to main contentSkip to account menu

68Ga-DOTA-Arg-Gly-Asp

Known as: 68Ga-DOTA-RGD, 68Ga-DOTA-arginine-glycine-aspartic acid, 68Ga-DOTA-arginyl-glycyl-aspartic acid 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Summary Aim: To retrospectively analyze the accuracy of absorbed dose estimates from a single measurement of the activity… 
2016
2016
ObjectivesTo quantify the additional value of 68Ga-DOTA-TATE PET/CT in comparison with contrast-enhanced CT alone for primary… 
2015
2015
Abstract Purpose: The aim of this study was to compare a Gd-based nanoparticle (AGuIX) with a standard extracellular Gd-based… 
Review
2010
Review
2010
AbstractBackground: Safety is a primary concern with contrast agents used for MRI. If precautions could be taken before the… 
2010
2010
Analogues of the E. coli heat-stable enterotoxin (STh) are currently under study as both imaging and therapeutic agents for… 
2009
2009
Background and Purpose— Vascular endothelial growth factor (VEGF) and VEGF receptors (VEGFRs) play important roles during… 
2009
2009
The purpose of this study was to examine the melanoma imaging properties of a novel 67Ga-labeled lactam bridge-cyclized alpha… 
Highly Cited
2005
Highly Cited
2005
Purpose: The therapeutic efficacy of a unique melanoma-targeting peptide conjugated with an in vivo generated α-particle-emitting… 
Highly Cited
2003
Highly Cited
2003
PURPOSE To compare the diagnostic accuracy of gadobenate dimeglumine (Gd-BOPTA)-enhanced versus gadoterate meglumine (Gd-DOTA… 
1994
1994
RATIONALE AND OBJECTIVES.Although gadolinium chelates are mainly eliminated by the kidney, there is limited information about…